Open AccessVancomycin intermediate-Resistant Staphylococcus aureus (VISA) Isolated from a patient who never received Vancomycin treatment
Author(s) -
Xuhui Zhu,
Cailin Liu,
Sui Gao,
Yanfang Lu,
Zhongju Chen,
Ziyong Sun
Publication year - 2014
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2014.12.038
Subject(s) - vancomycin , microbiology and biotechnology , autolysis (biology) , staphylococcus aureus , antibiotics , pulsed field gel electrophoresis , methicillin resistant staphylococcus aureus , typing , staphylococcus , multilocus sequence typing , biology , bacteria , genetics , genotype , enzyme , biochemistry , gene
With the abuse of antibiotics, the methicillin-resistant Staphylococcus aureus (MRSA) strain became prevalent. Furthermore, Staphylococcus aureus with a character of vancomycin intermediate-resistance (VISA) has been found globally since the first report in Japan. The main objectives of this study were to report a case of VISA isolated from a Chinese patient who had never undergone Vancomycin treatment, and to determine its molecular character.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom